§483.10(e) Respect and Dignity. The resident has a right to be treated with respect and dignity, including:
§483.10(e)(1) The right to be free from any . . . chemical restraints imposed for purposes of discipline or convenience, and not required to treat the resident's medical symptoms, consistent with §483.12(a)(2).
§483.12 The resident has the right to be free from abuse, neglect, misappropriation of resident property, and exploitation as defined in this subpart. This includes but is not limited to freedom from corporal punishment, involuntary seclusion and any physical or chemical restraint not required to treat the resident's medical symptoms. §483.12(a) The facility must-. . . §483.12(a)(2) Ensure that the resident is free from . . . chemical restraints imposed for purposes of discipline or convenience and that are not required to treat the resident's medical symptoms. . . . . §483.45(c)(3) A psychotropic drug is any drug that affects brain activities associated with mental processes and behavior. These drugs include, but are not limited to, drugs in the following categories: (i) Anti-psychotic; (ii) Anti-depressant; (iii) Anti-anxiety; and (iv) Hypnotic.
§483.45(d) Unnecessary drugs-General. Each resident's drug regimen must be free from unnecessary drugs. An unnecessary drug is any drug when used- (1) In excessive dose (including duplicate drug therapy); or (2) For excessive duration; or (3) Without adequate monitoring; or (4) Without adequate indications for its use; or (5) In the presence of adverse consequences which indicate the dose should be reduced or discontinued; or (6) Any combinations of the reasons stated in paragraphs (d)(1) through (5) of this section.
§483.45(e) Psychotropic Drugs. Based on a comprehensive assessment of a resident, the facility must ensure that--
§483.45(e)(1) Residents who have not used psychotropic drugs are not given these drugs unless the medication is necessary to treat a specific condition as diagnosed and documented in the clinical record;
§483.45(e)(2) Residents who use psychotropic drugs receive gradual dose reductions, and behavioral interventions, unless clinically contraindicated, in an effort to discontinue these drugs;
§483.45(e)(3) Residents do not receive psychotropic drugs pursuant to a PRN order unless that medication is necessary to treat a diagnosed specific condition that is documented in the clinical record; and
§483.45(e)(4) PRN orders for psychotropic drugs are limited to 14 days. Except as provided in §483.45(e)(5), if the attending physician or prescribing practitioner believes that it is appropriate for the PRN order to be extended beyond 14 days, he or she should document their rationale in the resident's medical record and indicate the duration for the PRN order. §483.45(e)(5) PRN orders for anti-psychotic drugs are limited to 14 days and cannot be renewed unless the attending physician or prescribing practitioner evaluates the resident for the appropriateness of that medication.
|
Observations:
Based on review of facility policy, clinical records and staff interview it was determined that the facility failed to make certain resident medication regimes were free from potentially unnecessary psychotropic medications for one of three residents (Resident R1 ).
Findings include:
Resident R1 was admitted on 12/29/25, and re-admitted to the facility on 1/28/26.
Review of Resident R1 MDS (minimum data set - a periodic assessment of resident needs) dated 1/8/26, indicated diagnosis of atrial fibrillation (irregular and often very rapid heart rhythm), and major depressive disorder recurrent (mood disorder that causes persistent feeling of sadness and loss of interest), and anxiety disorders (group of mental health conditions that cause fear , dread and other symptoms that are out of proportion to the situation) included on Resident R1 admit sheet.
Review of Resident R1 clinical record MAR (medication administration record) for February 2026 indicated:
Hydroxyzine Pamoate Capsule 50 MG Give 50 mg by mouth every 8 hours as needed for Anxiety for 14 Days -Start Date- 02/11/2026 2230 -D/C Date- 02/19/2026 1408
Lorazepam Oral Tablet 1 MG (Lorazepam) Give 1 mg by mouth every 8 hours as needed for anxiety for 14 Days -Start Date- 02/19/2026 1515 -D/C Date- 03/03/2026 1000
Review of the February MAR indicated: Hydroxyzine pamoate capsule 50 mg was given PRN (as needed) in February on the following days: 12, 13,14,15,16,17,18,and 19.
Review of the February MAR indicated: Lorazepam oral table 1 mg was given PRN (as needed) in February on the following days: 20,21, and 28.
Review of Resident R1 clinical records MAR for March 2026 indicated: Lorazepam Oral Tablet 1 MG (Lorazepam) Give 1 mg by mouth every 8 hours as needed for anxiety for 14 Days -Start Date- 02/19/2026 1515 -D/C Date- 03/03/2026 1000
Lorazepam Oral Tablet 1 MG (Lorazepam) Give 1 mg by mouth every 8 hours as needed for anxiety until 04/02/2026 23:59 -Start Date- 03/03/2026 1000
Review of the March MAR indicated Lorazepam oral tablet 1 mg was given PRN in March on the following days: 1, 2n,3,4,5,6,9,11,13,14,15,16,17, and 18.
Review of the MAR failed to include what behaviors Resident R1 was experiencing and other attempts to relive potential behaviors prior to Resident R1 being given the psychotropic medication.
Review of Resident R1 progress notes for February and March 2026 failed to include a description of behaviors, or non-pharmacological interventions that were given to Resident R1 prior to the psychotropic medications.
During an interview on 3/20/26, at 9:15 a.m. Director of Nursing confirmed that the facility failed to provide non-pharmacological interventions prior to giving anti-anxiety medications to Resident R1.
28 Pa Code: 201.14(a) Responsibility of licensee.
28 Pa. Code 211.12(d)(1)(3)(5) Nursing services.
| | Plan of Correction - To be completed: 05/04/2026
1. Resident R1 experienced no adverse effects. 2. Whole house audit of residents on psychotropic medications to be completed to determine behavior tracking and nonpharmacological interventions prior to administration of medication. 3. DON/designee to educate licensed nursing staff on behavior tracking and nonpharmacological interventions prior to administration of medication. 4. DON/designee to audit PRN antipsychotic use and documentation of nonpharmaceutical interventions weekly x 2 weeks, then monthly x 2 months. 5. Results to be submitted to QAPI for review and approval.
|
|